title: Spleen vagal denervation inhibits the production of antibodies to circulating antigens.
abstract: BACKGROUND
  Recently the vagal output of the central nervous system has been shown to suppress the innate immune defense to pathogens. Here we investigated by anatomical and physiological techniques the communication of the brain with the spleen and provided evidence that the brain has the capacity to stimulate the production of antigen specific antibodies by its parasympathetic autonomic output.
  
  
  RESULTS
  This conclusion was reached by successively demonstrating that: 1. The spleen receives not only sympathetic input but also parasympathetic input. 2. Intravenous trinitrophenyl-ovalbumin (TNP-OVA) does not activate the brain and does not induce an immune response. 3. Intravenous TNP-OVA with an inducer of inflammation; lipopolysaccharide (LPS), activates the brain and induces TNP-specific IgM. 4. LPS activated neurons are in the same areas of the brain as those that provide parasympathetic autonomic information to the spleen, suggesting a feed back circuit between brain and immune system. Consequently we investigated the interaction of the brain with the spleen and observed that specific parasympathetic denervation but not sympathetic denervation of the spleen eliminates the LPS-induced antibody response to TNP-OVA.
  
  
  CONCLUSIONS
  These findings not only show that the brain can stimulate antibody production by its autonomic output, it also suggests that the power of LPS as adjuvant to stimulate antibody production may also depend on its capacity to activate the brain. The role of the autonomic nervous system in the stimulation of the adaptive immune response may explain why mood and sleep have an influence on antibody production.
authors.affiliation: Instituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México, México, México.
authors.forename: Ruud M
authors.initials: RM
authors.lastname: Buijs
authors.forename: Jan
authors.initials: J
authors.lastname: van der Vliet
authors.forename: Mari-Laure
authors.initials: ML
authors.lastname: Garidou
authors.forename: Inge
authors.initials: I
authors.lastname: Huitinga
authors.forename: Carolina
authors.initials: C
authors.lastname: Escobar
mesh_terms: D000818:Animals; D000941:Antigens / Q000378:metabolism*; D001921:Brain / Q000378:metabolism; D003345:Corticosterone / Q000378:metabolism; D003714:Denervation; D011558:Herpesvirus 1, Suid / Q000378:metabolism; D007107:Immune System; D008070:Lipopolysaccharides / Q000737:chemistry / Q000494:pharmacology; D008953:Models, Anatomic; D019635:Neurosurgical Procedures; D010047:Ovalbumin / Q000737:chemistry; D010275:Parasympathetic Nervous System / Q000378:metabolism; D051381:Rats; D013154:Spleen / Q000276:immunology* / Q000294:innervation* / Q000502:physiology; D014630:Vagus Nerve / Q000473:pathology*
chemical_list: D000941:Antigens; D008070:Lipopolysaccharides; D010047:Ovalbumin; D003345:Corticosterone
references.citation: Nat Rev Immunol. 2006 Apr;6(4):318-28
references.pmid: 16557263
references.citation: Proc Natl Acad Sci U S A. 2006 Oct 24;103(43):16039-44
references.pmid: 17035503
references.citation: J Comp Neurol. 1996 Jan 01;364(1):51-67
references.pmid: 8789275
references.citation: Exp Biol Med (Maywood). 2007 Jan;232(1):14-26
references.pmid: 17202582
references.citation: J Comp Neurol. 2001 Mar 19;431(4):405-23
references.pmid: 11223811
references.citation: Nat Immunol. 2004 Oct;5(10):987-95
references.pmid: 15454922
references.citation: Trends Pharmacol Sci. 2004 Dec;25(12):640-6
references.pmid: 15530642
references.citation: Auton Neurosci. 2000 Dec 20;85(1-3):83-7
references.pmid: 11189031
references.citation: J Comp Neurol. 2003 Sep 8;464(1):36-48
references.pmid: 12866127
references.citation: Proc Natl Acad Sci U S A. 2006 Mar 28;103(13):5219-23
references.pmid: 16549778
references.citation: Nature. 2000 May 25;405(6785):458-62
references.pmid: 10839541
references.citation: J Neuroimmunol. 2003 Jun;139(1-2):150-4
references.pmid: 12799033
references.citation: Neuroendocrinology. 1985 Jan;40(1):2-24
references.pmid: 3969196
references.citation: Regul Pept. 2004 Jan 15;117(1):11-23
references.pmid: 14687696
references.citation: J Neurosci. 2004 Sep 1;24(35):7604-13
references.pmid: 15342726
references.citation: J Neuroendocrinol. 1996 Apr;8(4):299-307
references.pmid: 8861286
references.citation: Neuroscience. 1998 May;84(2):361-76
references.pmid: 9539210
references.citation: Proc Natl Acad Sci U S A. 2008 Aug 5;105(31):11008-13
references.pmid: 18669662
references.citation: Pharmacol Biochem Behav. 2005 Jan;80(1):115-21
references.pmid: 15652387
references.citation: J Clin Invest. 2003 Jan;111(2):241-50
references.pmid: 12531880
references.citation: Nat Rev Immunol. 2005 Mar;5(3):243-51
references.pmid: 15738954
references.citation: Psychoneuroendocrinology. 2001 Nov;26(8):761-88
references.pmid: 11585678
references.citation: Acta Biomed. 2007;78 Suppl 1:231-47
references.pmid: 17465337
references.citation: Nature. 2002 Dec 19-26;420(6917):853-9
references.pmid: 12490958
references.citation: J Clin Invest. 2002 Nov;110(9):1243-50
references.pmid: 12417562
references.citation: Proc Natl Acad Sci U S A. 2003 Sep 16;100(19):11148-52
references.pmid: 12960387
references.citation: Auton Neurosci. 2002 Jul 31;99(1):54-7
references.pmid: 12171257
references.citation: Infect Immun. 1971 Oct;4(4):452-5
references.pmid: 4949501
references.citation: J Comp Neurol. 1983 Sep 20;219(3):328-38
references.pmid: 6619341
references.citation: EMBO J. 2003 Jun 2;22(11):2546-51
references.pmid: 12773371
references.citation: Neuroscience. 2006 Jul 21;140(4):1415-34
references.pmid: 16650942
references.citation: Proc Natl Acad Sci U S A. 2005 Sep 13;102(37):13319-24
references.pmid: 16141324
references.citation: FASEB J. 2001 Jan;15(1):155-163
references.pmid: 11149903
references.citation: Am J Physiol. 1995 Aug;269(2 Pt 2):R437-44
references.pmid: 7653668
references.citation: Nature. 2003 Jan 23;421(6921):384-8
references.pmid: 12508119